CYCLERION THERAPEUTICS, INC.
|
(Name of Issuer)
|
Common Shares, no par value per share
|
(Title of Class of Securities)
|
23255M 105
|
(CUSIP Number)
|
Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge, MA 02142
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
April 2, 2019
|
(Date of Event which Requires Filing of this Statement)
|
1
|
NAMES OF REPORTING PERSONS
MFN Partners, LP
|
|||
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
(a) [ ]
(b) [X]
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
1,506,852
|
|
6
|
SHARED VOTING POWER
|
0
|
||
7
|
SOLE DISPOSITIVE POWER
|
1,506,852
|
||
8
|
SHARED DISPOSITIVE POWER
|
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,506,852
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
[ ]
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
5.5%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
PN
|
1
|
NAMES OF REPORTING PERSONS
MFN Partners GP, LLC
|
|||
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
(a) [ ]
(b) [X]
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
1,506,852
|
|
6
|
SHARED VOTING POWER
|
0
|
||
7
|
SOLE DISPOSITIVE POWER
|
1,506,852
|
||
8
|
SHARED DISPOSITIVE POWER
|
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,506,852
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
[ ]
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
5.5%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
OO
|
1
|
NAMES OF REPORTING PERSONS
MFN Partners Management, LP
|
|||
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
(a) [ ]
(b) [X]
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
1,506,852
|
|
6
|
SHARED VOTING POWER
|
0
|
||
7
|
SOLE DISPOSITIVE POWER
|
1,506,852
|
||
8
|
SHARED DISPOSITIVE POWER
|
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,506,852
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
[ ]
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
5.5%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
IA
|
1
|
NAMES OF REPORTING PERSONS
MFN Partners Management, LLC
|
|||
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
(a) [ ]
(b) [X]
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
1,506,852
|
|
6
|
SHARED VOTING POWER
|
0
|
||
7
|
SOLE DISPOSITIVE POWER
|
1,506,852
|
||
8
|
SHARED DISPOSITIVE POWER
|
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,506,852
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
[ ]
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
5.5%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
OO
|
1
|
NAMES OF REPORTING PERSONS
Farhad Nanji
|
|||
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
(a) [ ]
(b) [X]
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
United States
|
||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
1,506,852
|
|
6
|
SHARED VOTING POWER
|
0
|
||
7
|
SOLE DISPOSITIVE POWER
|
1,506,852
|
||
8
|
SHARED DISPOSITIVE POWER
|
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,506,852
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
[ ]
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
5.5%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
IN
|
1
|
NAMES OF REPORTING PERSONS
Michael DeMichele
|
|||
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
(a) [ ]
(b) [X]
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
United States
|
||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
1,506,852
|
|
6
|
SHARED VOTING POWER
|
0
|
||
7
|
SOLE DISPOSITIVE POWER
|
1,506,852
|
||
8
|
SHARED DISPOSITIVE POWER
|
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,506,852
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
[ ]
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
|
5.5%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
IN
|
Item 1.
|
|||||
(a)
|
Name of Issuer:
|
||||
Cyclerion Therapeutics, Inc.
|
|||||
(b)
|
Address of Issuer’s Principal Executive Offices:
|
||||
301 Binney Street
Cambridge, MA 02142 |
|||||
Item 2.
|
|||||
(a)
|
This Statement on Schedule 13G is being filed on behalf of:
|
||||
(i)
|
MFN Partners, LP, a Delaware limited partnership (the “Partnership”)
|
||||
(ii)
|
MFN Partners GP, LLC, a Delaware limited liability company (“MFN GP”), the General Partner of the Partnership
|
||||
(iii)
|
MFN Partners Management, LP, a Delaware limited partnership (“MFN Management”), the investment adviser to the Partnership
|
||||
(iv)
|
MFN Partners Management, LLC, a Delaware limited liability company (“MFN LLC”), the General Partner of MFN Management
|
||||
(v)
|
Farhad Nanji, in his capacities as managing member of MFN GP and MFN LLC
|
||||
(vi)
|
Michael DeMichele, in his capacities as managing member of MFN GP and MFN LLC
|
||||
(b)
|
Address of Principal Business Office or, if None, Residence:
|
||||
c/o MFN Partners Management, LP
222 Berkeley St., 13th Floor Boston, MA 02116 |
|||||
(c)
|
Citizenship:
|
||||
The Partnership
|
Delaware
|
||||
MFN GP
|
Delaware
|
||||
MFN Management
|
Delaware
|
||||
MFN LLC
|
Delaware
|
||||
Farhad Nanji
|
United States
|
||||
Michael DeMichele
|
United States
|
||||
(d)
|
Title and Class of Securities:
|
||||
Common stock, no par value per share
|
|||||
(e)
|
CUSIP No.:
|
||||
23255M 105
|
|||||
Item 3.
|
For statement filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c)
|
||||
Not applicable
|
|||||
Item 4.
|
Ownership
For the Partnership, MFN GP, MFN Management, MFN LLC, Farhad Nanji and Michael DeMichele
|
||||
(a)
|
Amount beneficially owned: 1,506,852
|
||||
(b)
|
Percent of Class: 5.5%
|
||||
(c)
|
Number of shares as to which the person has:
|
||||
(i)
|
Sole power to vote or to direct the vote: 1,506,852
|
||||
(ii)
|
Shared power to vote to direct the vote: 0
|
||||
(iii)
|
Sole power to dispose or to direct the disposition of: 1,506,852
|
||||
(iv)
|
Shared power to dispose or to direct the disposition of: 0
|
||||
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
||||
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner
of more than 5 percent of the class of securities, check the following [ ]
|
|||||
Item 6.
|
Ownership of more than Five Percent on Behalf of Another Person.
|
||||
Not applicable
|
|||||
Item 7.
|
Identification and classification of the subsidiary which acquired the security being reported on by the parent holding
company.
|
||||
Not Applicable
|
|||||
Item 8.
|
Identification and classification of members of the group.
|
||||
Not applicable
|
|||||
Item 9.
|
Notice of Dissolution of Group.
|
||||
Not applicable
|
|||||
Item 10.
|
Certification.
|
||||
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect,
other than activities solely in connection with a nomination under § 240.14a-11.
|
Dated: April 2, 2019 |
MFN PARTNERS, LP
|
|
|
By MFN Partners GP, LLC, its General Partner
|
|
||
|
|
|
|
By:
|
/s/ Jonathan Reisman
|
|
|
Name:
|
Jonathan Reisman
|
|
|
Title:
|
Authorized Person
|
|
|
MFN PARTNERS GP, LLC
|
|
||
|
|
|
|
By:
|
/s/ Jonathan Reisman
|
|
|
Name:
|
Jonathan Reisman
|
|
|
Title:
|
Authorized Person
|
|
|
|
MFN PARTNERS MANAGEMENT, LP
|
|
|
By MFN Partners Management, LLC, its General Partner
|
|||
|
|
|
|
|
By:
|
/s/ Jonathan Reisman
|
|
|
Name:
|
Jonathan Reisman
|
|
Title:
|
Authorized Person
|
||
MFN PARTNERS MANAGEMENT, LLC
|
|||
By:
|
/s/ Jonathan Reisman
|
||
Name:
|
Jonathan Reisman
|
||
Title:
|
Authorized Person
|
||
FARHAD NANJI
|
|||
/s/ Farhad Nanji |
|||
MICHAEL DEMICHELE
|
|||
/s/ Michael DeMichele |
|||
Exhibit 1.
|
Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
|
MFN PARTNERS, LP
|
|
||
By MFN Partners GP, LLC, its General Partner
|
|
||
|
|
|
|
By:
|
/s/ Jonathan Reisman
|
|
|
Name:
|
Jonathan Reisman
|
|
|
Title:
|
Authorized Person
|
|
|
MFN PARTNERS GP, LLC
|
|
||
|
|
|
|
By:
|
/s/ Jonathan Reisman
|
|
|
Name:
|
Jonathan Reisman
|
|
|
Title:
|
Authorized Person
|
|
|
|
MFN PARTNERS MANAGEMENT, LP
|
|
|
By MFN Partners Management, LLC, its General Partner
|
|||
|
|
|
|
|
By:
|
/s/ Jonathan Reisman
|
|
|
Name:
|
Jonathan Reisman
|
|
Title:
|
Authorized Person
|
||
MFN PARTNERS MANAGEMENT, LLC
|
|||
By:
|
/s/ Jonathan Reisman
|
||
Name:
|
Jonathan Reisman
|
||
Title:
|
Authorized Person
|
||
FARHAD NANJI
|
|||
/s/ Farhad Nanji |
|||
MICHAEL DEMICHELE
|
|||
/s/ Michael DeMichele |
|||